UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000014616
Receipt No. R000016969
Scientific Title A early phase II study using 19 personalized peptide vaccines (KRM-19) for metastatic recurrent triple negative breast cancer patients who had been resistant to standard treatment.
Date of disclosure of the study information 2014/08/01
Last modified on 2019/01/08 18:33:05

No. Disposal Last modified on Item of update
1 Insert 2014/07/23 09:32:28
2 Update 2019/01/08 18:33:05 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded


Contact us.